4DMedical is trading at A$3.86, up 5.18%, with no clear company-specific catalyst identified for August 24–25, 2026.
- Its latest official news was an August 17 partnership with Azra AI, predating the move.
- FY26 results are expected August 27, but coverage does not explicitly link them to the August 25 increase.
- Broadly flat equities provide no strong global-market explanation.